Announcement of Listed Companies in Shanghai Stock Exchange (September 19th)

  Renfu medicine: Nidanib ethanesulfonate soft capsule obtained drug registration certificate.

  () Announcement: Fupuke Pharmaceutical (Wuhan) Co., Ltd. (hereinafter referred to as "Wuhan Puke"), a wholly-owned subsidiary of the company, recently received the Drug Registration Certificate of Nidanib Esulfonate Soft Capsule approved and issued by National Medical Products Administration. Nidanib is a small molecule tyrosine kinase inhibitor. The approved indications of Nidanib Esulfonate Soft Capsule in Wuhan Puke are systemic sclerosis-related interstitial lung disease (SSc-ILD) and chronic fibrotic interstitial lung disease with progressive phenotype.

  The approval of Nidanib Esulfonate Soft Capsule indicates that the company has the qualification to sell the drug in the domestic market. This product further enriches the company’s product line, and its marketing will have a positive impact on the company.

  Shanghai Yashi: Suspension will continue on the morning of September 19th.

  () Announcement was issued. On September 14, 2023, the company received a notice from Jiangsu Yashi Investment Group Co., Ltd. (hereinafter referred to as "Yashi Group"), which was planning the transfer of shares, which may lead to the change of control rights of the company. In view of the major uncertainties in the above matters, in order to ensure fair information disclosure, safeguard the interests of investors and avoid abnormal fluctuations in the company’s share price, the company’s shares were suspended for two trading days on September 15 and September 18 after applying to the Shanghai Stock Exchange.

  During the suspension period, the parties to the transaction communicated further on related matters, and the company is not expected to resume trading on the morning of September 19th (Tuesday). According to the Listing Rules of Shanghai Stock Exchange, No.4 Self-regulatory Guidance for Listed Companies of Shanghai Stock Exchange-Suspension and Resumption of Trading, and other relevant regulations, the company’s shares will continue to be suspended from the morning of September 19th, 2023 (Tuesday), and the expected suspension time will not exceed three trading days.

  Zhejiang medicine: NCB003 for injection obtained the approval notice of drug clinical trial.

  () On the evening of September 18th, it was announced that Zhejiang Xinma Biomedical Co., Ltd., a subsidiary of the company, recently received the Notice of Approval for Clinical Trials of NCB003, a drug being researched by the company for injection, issued by National Medical Products Administration, and agreed to carry out clinical trials of this product as a single drug in advanced solid tumors.

  NCB003 for drug injection under research in Zhejiang Medicine was approved for clinical trials.

  Zhejiang Pharmaceutical announced that the company received the Notice of Approval for Clinical Trials of NCB003, a drug for injection under research, issued by National Medical Products Administration, and agreed to carry out clinical trials of this product as a single drug in advanced solid tumors.

  According to the announcement, NCB003 for injection is a new generation of fixed-point coupling long-acting human interleukin -2 drug independently developed by the company, which is intended to be used for advanced malignant solid tumors that have failed in standard treatment and belongs to innovative biotechnology drugs. The results of preclinical research show that NCB003 has significant inhibitory effect on a variety of transplanted tumors in vivo; NCB003 is relatively stable in blood circulation and its half-life is longer than that of IL -2. NCB003 is safe and tolerable near the effective dose and has a certain safety window.

  Yueda Investment: Capital increase of 265 million yuan to yueda Energy Storage Company, a wholly-owned subsidiary.

  () On the evening of September 18th, it was announced that in order to seize the development opportunity of energy storage, promote the smooth landing of energy storage power station projects and open up the energy storage business market, the company increased its capital by 265 million yuan to its wholly-owned subsidiary, yueda Energy Storage Company. This part of the capital increase is used for yueda Energy Storage Company to invest in Funing and Guannan two large-scale shared energy storage power stations.

  Yueda Investment plans to increase the capital of its subsidiary yueda Energy Storage Company by 265 million yuan to open up the energy storage business market.

  Yueda Investment announced that in order to seize the opportunity of energy storage development, promote the smooth landing of energy storage power station projects, open up the energy storage business market and enhance the company’s core competitiveness, the company increased its capital by 265 million yuan to Jiangsu yueda Energy Storage Technology Co., Ltd. (hereinafter referred to as "yueda Energy Storage Company"), a wholly-owned subsidiary. After this capital increase, the registered capital of yueda Energy Storage Company increased to 300 million yuan. This part of the capital increase is used for yueda Energy Storage Company to invest in Funing and Guannan two large-scale shared energy storage power stations.

  The company said that this capital increase is in line with the company’s industrial positioning of "new energy, new materials and intelligent manufacturing", in line with the national policy orientation of energy structure adjustment and reform, and will help the company’s energy storage industry become bigger and stronger, help the company’s transformation and upgrading, and meet the company’s long-term development goals and the interests of all shareholders.

  66 million shares of Opal Lighting’s controlling shareholder were pledged.

  () Announcement: The 66 million shares of the company (accounting for 8.84% of the company’s total share capital) held by Zhongshan Opple Investment Co., Ltd. ("Zhongshan Opple") have been released from pledge.

  (): The wholly-owned subsidiary signed an Asset Transfer Contract of 16.6 million yuan.

  Junhe shares announced on the evening of September 18th that Junhe Cable, a wholly-owned subsidiary, and Pengyue Auto Parts recently signed the Asset Transfer Contract for Junhe Cable’s two industrial lands, four buildings and ancillary facilities in Xinwu Economic Development Zone, with a transaction amount of 16.6 million yuan.

  Junhe Cable, a subsidiary of Junhe Co., Ltd., plans to sell some land and related assets.

  Junhe Co., Ltd. announced that based on the company’s development strategic planning, in order to facilitate the company’s overall management, further improve the efficiency of management decision-making, continuously promote the integration of internal resources, and realize the most effective allocation of the company’s resources, Junhe Cable, a wholly-owned subsidiary of the company, sold its two industrial lands, four buildings, ancillary facilities and others located in Xinwu Economic Development Zone to Pengyue Auto Parts for RMB 16.6 million, and signed an Asset Transfer Contract.

  Chengyi Pharmaceutical Co., Ltd.: The holding subsidiary obtained the notice of approval for the listing application of glucosamine hydrochloride chemical raw materials.

  () On the evening of September 18th, it was announced that Fujian Huakang, a holding subsidiary, received the Notice of Approval for the Application for Listing of Chemical Raw Materials for Glucosamine Hydrochloride, which was approved and issued by National Medical Products Administration. Glucosamine Hydrochloride was mainly used for the treatment of osteoarthritis and dietary supplements.

  The listing application of glucosamine hydrochloride chemical raw material drug of Chengyi Pharmaceutical Company was approved.

  Chengyi Pharmaceutical announced that recently, Fujian Huakang Pharmaceutical Co., Ltd. (referred to as "Fujian Huakang"), a holding subsidiary of the company, received the Notice of Approval for the Listing Application of Chemical Raw Materials for glucosamine hydrochloride approved and issued by National Medical Products Administration.

  Glucosamine is a natural amino monosaccharide, which is the precursor of proteoglycan. It can stimulate chondrocytes to produce proteoglycan with normal polymer structure, improve the repair ability of chondrocytes, prevent the generation of superoxide radicals that damage cells, and promote the repair and reconstruction of cartilage matrix, thus delaying the pathological process and disease process of joint pain, improving joint activity and relieving pain. Glucosamine hydrochloride is mainly used in the treatment of osteoarthritis and dietary supplements, which is a natural component of glycoprotein in joint tissues of human bodies and animals, and has the function of repairing and maintaining cartilage and joint functions. Up to now, Fujian Huakang has invested about 3.89 million yuan (unaudited) in the R&D project of glucosamine hydrochloride.

  This time, the subsidiary obtained the Notice of Approval for the Listing Application of Glucosamine Hydrochloride, which shows that the raw material drug meets the relevant national technical standards for drug approval and can be produced and sold in the domestic market, which will further enrich the product line of the subsidiary and help expand its business field.

  Shangbo Pharmaceutical, a subsidiary of Shengquan Group, was approved to be listed on the New Third Board.

  () Announcement: Jinan Shangbo Pharmaceutical Co., Ltd. (hereinafter referred to as "Shangbo Pharmaceutical"), a holding subsidiary of the company, recently received the Letter on Agreeing to the Public Transfer of Shares of Jinan Shangbo Pharmaceutical Co., Ltd. and Listing in the National Share Transfer System (Share Transfer Letter [2023] No.2826) issued by the National Small and Medium-sized Enterprise Share Transfer System (hereinafter referred to as the "New Third Board"), and agreed to the public transfer of shares of Shangbo Pharmaceutical.

  Shangbo Pharmaceutical’s listing on the New Third Board is conducive to broadening financing channels, promoting its sustained and healthy development, maximizing the overall benefits of the company, enhancing its market competitiveness, and conforming to the company’s long-term development strategy.

  The two directors of Dongwei Technology, Jiangao, terminated the reduction of shares in advance and cashed in a total of 10.88 million yuan.

  On September 16, Dongwei Technology announced the results of directors and supervisors’ early termination of the reduction plan and centralized bidding to reduce their shares. On September 15th, the Company received the Notice Letter of Early Termination of the Share Reduction Plan issued by Director Shi Guowei and Chairman Zhong Jincai respectively. Based on their confidence in the company’s future development prospects, their overall judgment on the company’s value and the current market environment, Shi Guowei and Zhong Jincai decided to terminate the share reduction plan ahead of schedule.

  On September 15th, Shi Guowei reduced the number of shares of the company by 150,000 shares, with a reduction ratio of 0.07%. The reduction price range was 55.56 yuan to 56.78 yuan, with a total reduction of 8,385,200 yuan, and the number of shares that were not reduced was 470,000 shares. On September 5, Zhong Jincai reduced the number of shares of the company by 39,400 shares, with a reduction ratio of 0.02%. The reduction price range was 63.00 yuan to 63.67 yuan, and the total reduction amount was 2,490,100 yuan. The number of shares that were not reduced was 360,600 shares.

  After calculation, Shi Guowei and Zhong Jincai cashed in a total of 10,875,300 yuan.

  Before the reduction, Shi Guowei directly held 3,134,900 shares of the company, accounting for 1.37% of the company’s total share capital; Zhong Jincai directly holds 1,789,500 shares of the company, accounting for 0.78% of the company’s total share capital. After the reduction, Shi Guowei holds 2,984,900 shares of the company, with a shareholding ratio of 1.30%; Zhong Jincai holds 1.75 million shares of the company, with a shareholding ratio of 0.76%.

  Previously, Dongwei Technology disclosed the Announcement of Directors and Supervisors of Kunshan Dongwei Technology Co., Ltd. on July 6 (AnnouncementNo.: 2023-037), and Shi Guowei planned to reduce the number of shares by no more than 620,000 shares, accounting for no more than 0.27% of the company’s total share capital. The reduction through centralized bidding shall be carried out within 6 months after 15 trading days from the date of announcement of the reduction plan.

  On July 13th, Dongwei Technology disclosed the Announcement on the Plan of Centralized Bidding by Dong Jiangao and Core Technicians of Kunshan Dongwei Technology Co., Ltd. (AnnouncementNo.: 2023-040), and Zhong Jincai planned to reduce his shareholding by no more than 400,000 shares, accounting for no more than 0.17% of the company’s total share capital. The reduction through centralized bidding shall be carried out within 6 months after 15 trading days from the date of announcement of the reduction plan.

  Dongwei Technology’s 2022 annual report shows that Shi Guowei has been a director and sales director of the company since May 2019; Since May 2011, Zhong Jincai has served as the chairman and business director of the company’s board of supervisors.

  Shengquan Group: The holding subsidiary received the letter of approval for listing of the national share transfer system for small and medium-sized enterprises.

  Shengquan Group announced on the evening of September 18th that Shangbo Pharmaceutical, a holding subsidiary, recently received the Letter on Agreeing to the Public Transfer of Jinan Shangbo Pharmaceutical Co., Ltd. and Listing in the National Share Transfer System issued by the National Small and Medium-sized Enterprise Share Transfer System Co., Ltd., and agreed to the public transfer of Shangbo Pharmaceutical shares and listing in the National Small and Medium-sized Enterprise Share Transfer System, with the transaction method of call auction.

  Kesi Technology: It is planned to build a production base of electronic information equipment in Jiangning Development Zone.

  Keshi Technology announced on the evening of September 18th that the company plans to sign the Investment Intention Agreement with the Management Committee of Jiangning Development Zone, and the company plans to build a production base of electronic information equipment in Nanjing Jiangning Economic and Technological Development Zone.

  Yuan Jianfeng, a shareholder of Jinghua Laser, reduced his shareholding by 486,900 shares, with a shareholding ratio of less than 5%.

  () Recently, it was announced that the company received the Simplified Report on Changes in Equity issued by shareholder Yuan Jianfeng on September 14, 2023. After this equity change, shareholder Yuan Jianfeng directly held 2,367,272 shares of the company and indirectly held 6,558,561 shares, accounting for 4.999996% of the company’s total share capital, and was no longer a shareholder holding more than 5% of the company’s shares.

  Jinghua Laser announced that on September 14th, Yuan Jianfeng reduced his holdings by 486,900 shares through centralized bidding, accounting for 0.272747% of the company’s total share capital.

  Jinghua Laser pointed out that this equity change does not touch the tender offer and does not involve the source of funds. This change in equity will not lead to changes in the controlling shareholder and actual controller of the company, and will not have a significant impact on the corporate governance structure and going concern. After this equity change, Mr. Yuan Jianfeng is no longer a shareholder holding more than 5% of the company’s shares. In case of subsequent equity changes, the information disclosure obligor will perform information disclosure and other related obligations in accordance with laws and regulations.

  KES Technology: The electronic information equipment production base is planned to land in Nanjing Jiangning Economic Development Zone.

  Kesi Technology announced that the company plans to sign the Investment Intention Agreement with the Management Committee of Nanjing Jiangning Economic and Technological Development Zone, and the company plans to build a production base for electronic information equipment in Nanjing Jiangning Economic and Technological Development Zone.

  According to the announcement, the project plot is located in the south of Zhengfang Avenue, north of Innovation Avenue and west of Science and Technology South Road in Jiangning Development Zone, and the nature of the project plot is industrial land. The investment intention agreement to be signed this time is not expected to have a significant impact on the company’s performance in 2023.

  () The wholly-owned subsidiary won the business layout of Jinbo South District, North District Land and other assets optimization company by bidding for 79.3308 million yuan.

  JuHeshun announced that Changde JuHeshun New Materials Co., Ltd. ("Changde JuHeshun"), a wholly-owned subsidiary of the company, won the land, houses, machinery and equipment and ancillary facilities in the south and north areas of Hunan Jinbo Chemical Fiber Co., Ltd. ("Jinbo") at a bid price of RMB 79.3308 million; The starting price of this auction is RMB 79.3308 million, and the bid bond is RMB 4 million.

  In recent years, the company and its wholly-owned subsidiary Changde Juhe Shun signed a lease contract with the manager of Jinbo to lease the assets related to Jinbo for production to solve the problem of insufficient production capacity of the company. Obtaining relevant assets in this auction will help to further optimize the company’s business layout, enhance economies of scale, consolidate the company’s brand influence and further enhance the company’s industry position.

  Qiu Wensheng, Chairman of Hua Qin Technology, and other four directors and senior executives increased their holdings by 70,000 shares.

  () Announcement. As of the disclosure date of this announcement, the actual controller, chairman and general manager Qiu Wensheng, vice chairman Cui Guopeng, director and deputy general manager Wu Zhenhai and director Chen Xiaorong of the company have increased their holdings of 70,000 shares by centralized bidding trading through the trading system of Shanghai Stock Exchange, accounting for 0.0097% of the company’s total share capital, with a cumulative increase of RMB 4,827,700. The increase plan has not yet been implemented.

  Zhongbei Communication: Signed a 180 million yuan AI computing service contract

  () It was announced on the evening of September 18th that the company (Party B) and Jinan Supercomputing Center Co., Ltd. (Party A) signed the AI Computing Service Contract and its annex "Computing Service List". In view of Party B’s ability to provide AI computing services, Party A purchased AI computing services from the intelligent computing center. The contract amount is 180 million yuan and the service period is 60 months.

  Zhongbei Communication signed a 180 million yuan AI computing service contract with Jinan Supercomputing Center.

  Zhongbei Communication announced that recently, the company signed the AI Computing Service Contract with Jinan Supercomputing Center Co., Ltd. and its annex "Computing Service List". In view of the company’s ability to provide AI computing services, Jinan Supercomputing Center purchased AI computing services from the company. The contract amount is 180 million yuan, and the service period is 60 months, counting from the date of successful delivery. The specific payment amount is based on the actual number of servers delivered to users for operation.

  The smooth performance of this contract is expected to have a positive impact on the company’s current and future financial situation and operating results. The signing of the contract conforms to the overall planning of the company’s intelligent calculation business and is conducive to promoting the development of the company’s intelligent calculation business.

  In order to deeply participate in the housing leasing business, Shanghai Construction Engineering’s subsidiary company plans to spend 1.2 billion yuan to participate in the construction fund.

  () Announcement: Shanghai Construction Engineering Group Investment Co., Ltd. (hereinafter referred to as "Construction Engineering Investment"), a wholly-owned subsidiary of the company, and its subsidiary Shanghai Construction Engineering Equity Investment Fund Management Co., Ltd. (hereinafter referred to as "Construction Engineering Fund") signed the Partnership Agreement of Shanghai Jianshen Housing Leasing Private Investment Fund (Limited Partnership) with CCB Housing Leasing Private Fund Management Co., Ltd. and CCB Housing Leasing Fund (Limited Partnership), and jointly initiated the establishment of Shanghai Jianshen Housing Leasing Private Investment Fund Partnership.

  The scale of the fund is 3 billion yuan, of which 1.199 billion yuan is invested by Construction Engineering Investment as a limited partner LP and 1 million yuan is invested by Construction Engineering Fund as a general partner GP. The fund will adhere to the basic orientation of investing in rental housing, mainly investing in the existing assets such as self-sustaining houses, commercial properties, industrial properties, etc. in Shanghai. At the same time, according to the housing rental market in Shanghai, it will actively explore the rental housing investment model with local characteristics.

  It is reported that this matter will provide more opportunities for the company to deeply participate in the housing leasing business, stimulate the main business of architecture and design, help to enhance the brand influence of Shanghai Construction Engineering, and further strengthen the company’s competitive advantage in the field of urban renewal.

  KES Technology: It is planned to build an electronic information equipment production base project in Jiangning Development Zone.

  Kesi Technology announced that the company plans to sign the Investment Intention Agreement with the Management Committee of Nanjing Jiangning Economic and Technological Development Zone, and the company plans to build an electronic information equipment production base project in Nanjing Jiangning Economic and Technological Development Zone (hereinafter referred to as "Jiangning Development Zone"). Through this cooperation, the company will make full use of the superior resources of Jiangning Development Zone, which is conducive to the development and innovation of the company’s electronic information equipment production base construction project.

  Chengyi Pharmaceutical Co., Ltd.: The application for listing glucosamine hydrochloride was approved.

  Chengyi Pharmaceutical announced that Fujian Huakang, a holding subsidiary of the company, received the Notice of Approval for the Listing Application of Chemical Raw Materials for Glucosamine Hydrochloride, which was approved and issued by National Medical Products Administration. Glucosamine hydrochloride is mainly used in the treatment of osteoarthritis and dietary supplements, which is a natural component of glycoprotein in joint tissues of human bodies and animals, and has the function of repairing and maintaining cartilage and joint functions.

  Shanghai Yashi: The controlling shareholder plans to change the control right, and the stock continues to be suspended.

  Shanghai Yashi announced that Jiangsu Yashi Investment Group Co., Ltd., the controlling shareholder of the company, planned the share transfer, which may lead to the change of the company’s control rights. The parties to the transaction need to communicate further on related matters. The company is not expected to resume trading on the morning of September 19, and the company’s shares will continue to be suspended. It is expected that the suspension will not exceed three trading days.

  Chuantou Energy: It is planned to invest in the first batch of distributed photovoltaic projects in Rongxian County.

  () Announcement: Rongxian Yipan New Energy Co., Ltd., which is to be invested by Sichuan Investment (Panzhihua) New Energy Development Co., Ltd., is the main investor to invest in the first batch of distributed photovoltaic projects in Rongxian County, and the total investment of the project is controlled within 6,699,400 yuan. It is planned to inject 3 million yuan of capital into Sichuan Investment (Panzhihua) New Energy Development Co., Ltd. to increase the capital of Yipan Company.

  Chengbang Co., Ltd. intends to reduce the capital of its subsidiaries Chengbang Environmental Protection, Chengbang Design and Chengbang Investment.

  () Announced that, based on the company’s overall development plan and the actual operating conditions of Chengbang Environmental Protection, Chengbang Design and Chengbang Investment, in order to integrate resources, optimize allocation and control investment risks, the company plans to adjust the existing registered capital scale of its wholly-owned subsidiaries, namely, the registered capital of Chengbang Environmental Protection will be reduced from 62.5 million yuan to 27.1 million yuan, and the company will reduce its subscribed capital by 35.4 million yuan. The registered capital of Chengbang Design was reduced from 133.16 million yuan to 68 million yuan, and the company reduced its subscribed capital by 65.16 million yuan; The registered capital of Chengbang Investment decreased from 203.16 million yuan to 10 million yuan, and the company reduced its subscribed capital by 193.16 million yuan. This capital reduction will not lead to changes in the shareholding structure of Chengbang Environmental Protection, Chengbang Design and Chengbang Investment, and the company still holds 100% equity.

  This capital reduction is based on the overall development plan and the actual operating conditions of Chengbang Environmental Protection, Chengbang Design and Chengbang Investment, and it is beneficial to improve the overall operation and capital utilization efficiency of the company, without affecting the normal business development of Chengbang Environmental Protection, Chengbang Design and Chengbang Investment.

  11,001,100 restricted shares of Huawang Technology will be listed and circulated on September 25th.

  () Announcement, the company issued restricted shares in a non-public manner. The total number of shares listed and circulated this time is 11,001,100 shares, and the listing date is September 25, 2023.

  Sinopharm Modern: Lidocaine Hydrochloride Obtained the Approval Notice for the Marketing Application of Chemical Raw Materials.

  () Announcement: Shanghai Hyundai Hasen (Shangqiu) Pharmaceutical Co., Ltd. ("Sinopharm Hasen"), a holding subsidiary of the company, received the Notice of Approval for Listing Application of Chemical Raw Materials with Lidocaine Hydrochloride approved and issued by National Medical Products Administration.

  It is reported that lidocaine hydrochloride is a local anesthetic and antiarrhythmic drug, which is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block, and can also be used for ventricular premature contraction and ventricular tachycardia after acute myocardial infarction, digitalis poisoning, cardiac surgery and ventricular arrhythmia caused by cardiac catheter.

  About 284 million restricted shares of GM will be listed and circulated on September 22nd.

  () Announced that the total number of shares listed and circulated this time is about 284 million shares, and the listing date is September 22, 2023.

  Jianfeng Group: The subsidiary obtained the approval notice for the supplementary application of mycophenolate mofetil capsules.

  () On the evening of September 18th, it was announced that Jianfeng Pharmaceutical Co., Ltd., a wholly-owned subsidiary, received National Medical Products Administration’s Notice of Approval for Drug Supplement Application for Mycophenolate mofetil capsules. This product is suitable for the induction treatment and maintenance treatment of adult patients with type III-V lupus nephritis.

  Sinopharm Hyundai: The holding subsidiary obtained the approval notice for the listing application of lidocaine hydrochloride.

  On the evening of September 18th, Sinopharm Hyundai announced that its holding subsidiary Sinopharm Hasen had received the Notice of Approval for Listing Application of Chemical Raw Materials with Lidocaine Hydrochloride approved and issued by National Medical Products Administration. Lidocaine hydrochloride is a local anesthetic and antiarrhythmic drug, which is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block.

  Jianfeng Group: The application for drug supplement of mycophenolate mofetil capsules was approved.

  Jianfeng Group issued an announcement. Recently, Zhejiang Jianfeng Pharmaceutical Co., Ltd. ("Jianfeng Pharmaceutical"), a wholly-owned subsidiary of the company, received National Medical Products Administration’s Notice of Approval for Drug Supplement Application for Mycophenolate mofetil Capsules. After review, this product passed the consistency evaluation of generic drug quality and efficacy, and agreed to change the prescription process and quality standard, with a validity period of 24 months.

  It is reported that this product is used at the same time with corticosteroids and cyclosporine or tacrolimus, and is suitable for treatment: preventing organ rejection in patients receiving allogeneic kidney transplantation; Prevention of organ rejection in patients receiving allogeneic liver transplantation; This product is suitable for the induction treatment and maintenance treatment of III-V adult lupus nephritis patients.

  According to the announcement, this time, Jianfeng Pharmaceutical obtained the Notice of Approval for Drug Supplement Application of Mycophenolate mofetil Capsules, which indicates that the drug has passed the consistency evaluation of generic drug quality and efficacy, which is conducive to expanding the market share of the drug and enhancing its market competitiveness.

  2.8 million restricted shares of Juguang Technology will be listed and circulated on September 25th.

  Juguang Technology announced that the company’s initial public offering of restricted shares was 2.8 million shares, and the listing date was September 25, 2023.

  Di Hao, Vice President of Xi ‘an Bank, holds 216,500 shares of the company.

  (Announcement) In recognition of the confidence and growth value of the company’s future development prospects, Di Haoji, the vice president of the company, increased his holding of 216,500 shares by centralized bidding through the trading system of Shanghai Stock Exchange from September 15 to September 18, 2023, accounting for 0.0049% of the company’s total share capital.

  Xi ‘an Bank: The vice president recently increased his holding of 216,500 shares in the company.

  On the evening of September 18th, Xi ‘an Bank announced that it had received a notice from Di Hao, the vice president, to increase its shareholding in the company. From September 15th to September 18th, 2023, it increased its shareholding by 216,500 shares, accounting for 0.0049% of the company’s total share capital.

  Shanghai Pudong Development Bank: Appointed Li Guoguang as General Manager of Asset Custody Department.

  According to the announcement of Shanghai Pudong Development Bank, Li Guoguang was appointed as the general manager of the company’s asset custody department to take charge of the related work of the asset custody department. Li Guoguang’s custodian senior management information has been filed in asset management association of china.

  Tianma Zhikong: Xing Shihong resigned as the secretary-general and chief accountant, and Li Shoubin resigned as the vice chairman.

  Tianma Zhikong announced that the board of directors of the company recently received the resignation report of Li Shoubin, vice chairman and director of the company. Li Shoubin applied to resign as vice chairman and director of the company due to job changes.

  The board of directors of the company recently received the resignation report of Xing Shihong, secretary of the board of directors and chief accountant of the company. Xing Shihong resigned as secretary of the board of directors and chief accountant of the company due to his retirement application, and the resignation report will take effect when it is delivered to the board of directors of the company.

  The controlling shareholder of Xinhuajin pledged 6.50% of its shares.

  () Announcement was issued. On September 15, 2023, the controlling shareholder Lujin Group pledged 27.87 million shares (accounting for 15.02% of its shares and 6.50% of the total share capital) of the company’s unrestricted shares.

  Xi ‘an Bank: Vice President Di Hao holds 216,500 shares of the company.

  Xi ‘an Bank announced that it had received a notice from Di Hao, the vice president, to increase the company’s shares. According to the announcement, Di Hao increased his holdings in the secondary market with his own funds. This time, he increased his holdings by 216,500 shares, accounting for 0.0049% of the company’s total share capital. After the increase, he held 228,945 shares, accounting for 0.0052% of the company’s total share capital. The price range of this increase is 3.57-3.65 yuan/share, and the increase time is from September 15 to September 18, 2023.

  Jinyu Medicine: It is planned to buy back shares at a price of RMB 30 million to RMB 50 million.

  () Announcement, it is planned to buy back shares at a price of RMB 30 million to RMB 50 million, and the repurchase price shall not exceed RMB 75 yuan per share.

  Jinyu Medical plans to spend 30 million yuan to 50 million yuan to buy back shares for equity incentives.

  Jinyu Medical announced that the company plans to spend 30 million yuan to 50 million yuan to buy back shares, and the repurchased shares will be used for the company’s equity incentive, and the repurchase price will not exceed 75 yuan/share.

  Jianyuan Trust and Wang Shaoqin and other three people received 4 warning letters and deposited 5 letters that violated the rules.

  () Announced on the evening of September 15th that the company and relevant personnel received the warning letter from Shanghai Securities Regulatory Bureau.

  On September 15th, 2023, the Company and relevant personnel received the Decision on Taking Measures to Issue Warning Letters to Jianyuan Trust Co., Ltd. (No.223 [2023] of Shanghai Securities Regulatory Commission) and the Decision on Taking Measures to Issue Warning Letters to Wang Shaoqin (No.224 [2023] of Shanghai Securities Regulatory Commission). Decision on Taking Measures to Issue Warning Letter to Yang Xiaobo (No.225 [2023] of Shanghai Securities Regulatory Commission) and Decision on Taking Measures to Issue Warning Letter to Shao Mingan (No.226 [2023] of Shanghai Securities Regulatory Commission) (hereinafter referred to as "Warning Letter"). After investigation, there are five problems in ST Jianyuan.

  1. Major contracts are not disclosed as required. Since 2014, ST Jianyuan has signed trust beneficiary transfer agreements, beneficiary transfer contracts and business cooperation agreements with some trust beneficiaries in the process of conducting trust business. The company did not disclose it in time in the interim announcement, nor did it disclose it in the annual report from 2015 to 2018 and the semi-annual report from 2015 to 2019. It was not until November 12, 2019 that the company first disclosed the existence of the above-mentioned long-term transfer and other forms of guarantee commitment in the reply announcement to the exchange inquiry letter, and it was not until April 30, 2021 that the amount of the above-mentioned guarantee commitment contract was disclosed in the 2020 annual report.

  2. The external guarantee fails to perform the review procedure and is not disclosed as required. ST Jianyuan issued the Letter of Guarantee in October 2016, stipulating that the insured shall bear irrevocable joint and several liability when the transferee fails to fulfill the obligation as scheduled, involving a guarantee principal of 700 million yuan. In April 2021, the above guarantee obligation was lifted. The company did not perform the deliberation procedures of the board of directors and shareholders’ meeting on this matter, and it was not disclosed in the interim announcement, nor in the annual report from 2016 to 2020 and the semi-annual report from 2017 to 2020.

  3. Major litigation is not disclosed as required. In 2019, ST Jianyuan, as the defendant, was involved in litigation because of signing an agreement on the transfer of beneficial rights and a contract for the transfer of beneficial rights. However, the company did not disclose the above litigation matters in time, nor did it disclose it in the 2019 semi-annual report, and it was not disclosed until November 16, 2019, December 17, 2019 and April 30, 2020. In 2019, 2020 and January 2021, the company was involved as a plaintiff. The company did not disclose the above litigation matters in time, nor did it disclose it in the 2019 annual report and the 2019 and 2020 semi-annual reports. It was not until April 30, 2021 that the amount involved in the lawsuit was disclosed in the 2020 annual report.

  4. The main assets are pledged or frozen and not disclosed as required. From 2019 to March 2020, many assets of ST Jianyuan were pledged or frozen. The company did not disclose the above-mentioned asset restrictions in time, nor did it disclose them completely and accurately in the 2019 semi-annual report and annual report. It was not until May 15, 2020 that the assets pledge was frozen in the form of a temporary announcement.

  5. The occupation of non-operating funds by related parties is not disclosed as required. On December 30, 2017, ST Jianyuan issued a trust loan of 500 million yuan through the trust plan. In January 2018, 297 million yuan of the above funds was indirectly transferred to the account of Shanghai Guozhijie Investment Development Co., Ltd., the original controlling shareholder of the company. In December 2018, the company subscribed for part of the above trust plan with an inherent capital of 181.4 million yuan. In April 2021, the company received the above trust share transfer payment.

  As the chairman of Anxin Trust from November 2012 to May 2019, Wang Shaoqin failed to perform his duties diligently, and was responsible for the failure to disclose the company’s major contracts, external guarantees, and non-operating funds occupied by related parties, which violated the provisions of Articles 3, 38 and 40 of the Administrative Measures for Information Disclosure of Listed Companies (Order No.40 of CSRC).

  From November 2012 to October 2018, Yang Xiaobo, as the president of Essence Trust, failed to perform his duties diligently, and was responsible for the failure to disclose the company’s major contracts, the failure to perform the review procedures and the failure to disclose the external guarantees, which violated the provisions of Articles 3, 38, 40 and 44 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.40 of the CSRC).

  Shao Mingan served as a director of Anxin Trust from November 2012 to September 2022, performed the duties of chairman from July 2019 to January 2020, and performed the duties of president from October 2018 to April 2019. He failed to perform his duties diligently and was responsible for the above matters of the company, which violated Articles 3, 38 and 1 of the Administrative Measures for Information Disclosure of Listed Companies (Order No.40 of the CSRC).

  According to Item 3 of Article 59 of the Administrative Measures for Information Disclosure of Listed Companies (Order No.40 of CSRC), Shanghai Securities Regulatory Bureau adopted the supervision measures of issuing a warning letter to ST Jianyuan. According to Article 58 and Item 3 of Article 59 of the Measures for the Administration of Information Disclosure of Listed Companies, the Shanghai Securities Regulatory Bureau decided to issue warning letters to Wang Shaoqin, Yang Xiaobo and Shao Mingan.

  On June 29, 2023, ST Anxin issued an implementation announcement on changing the abbreviation of the company’s securities. Jianyuan Trust Co., Ltd. held the fourth meeting of the ninth board of directors on December 23, 2022, and the first extraordinary general meeting of shareholders in 2023 on January 9, 2023. The Proposal on Changing Company Name and Securities Abbreviation was reviewed and passed. In order to meet the needs of the company’s development, it was agreed that the company name should be changed from Anxin Trust Co., Ltd. to Jianyuan Trust Co., Ltd. and the securities abbreviation should be ST Anxin.

  According to the announcement, since the company name has been changed from Anxin Trust Co., Ltd. to Jianyuan Trust Co., Ltd., in order to make the company’s securities abbreviation match the company name, the company changed the stock abbreviation from "ST Anxin" to "ST Jianyuan" and the stock code remained unchanged.

  Relevant regulations:

  Article 58 of the Measures for the Administration of Information Disclosure of Listed Companies: Directors, supervisors and senior managers of listed companies shall be responsible for the truthfulness, accuracy, completeness, timeliness and fairness of company information disclosure, unless there is sufficient evidence to show that they have fulfilled their due diligence obligations.

  The chairman, manager and secretary of the board of directors of a listed company shall be mainly responsible for the truthfulness, accuracy, completeness, timeliness and fairness of the information disclosure of the company’s interim report.

  The chairman, manager and financial officer of a listed company shall bear the main responsibility for the authenticity, accuracy, completeness, timeliness and fairness of the company’s financial report.

  Article 59 of the Measures for the Administration of Information Disclosure of Listed Companies: If the information disclosure obligor and its directors, supervisors and senior managers, shareholders, actual controllers, purchasers and their directors, supervisors and senior managers of listed companies violate these Measures, the China Securities Regulatory Commission may take the following regulatory measures:

  (a) shall be ordered to make corrections;

  (2) Supervision talk;

  (3) issuing a warning letter;

  (four) the violation of laws and regulations, non-performance of public commitments, etc. are recorded in the integrity file and published;

  (five) identified as inappropriate candidates;

  (6) Other regulatory measures that can be taken according to law.

  Warning letter content:

  Decision on Taking Measures to Issue Warning Letter to Jianyuan Trust Co., Ltd. (No.223 [2023] of Shanghai Securities Regulatory Commission)

  Jianyuan Trust Co., Ltd.:

  After investigation, your company has the following problems.

  1. Major contracts are not disclosed as required. Since 2014, in the process of conducting trust business, your company has signed trust beneficial right transfer agreements, beneficial right transfer contracts and business cooperation agreements with some trust beneficiaries. Your company did not disclose it in time in the interim announcement, nor in the annual report from 2015 to 2018 and the semi-annual report from 2015 to 2019. It was not until November 12, 2019 that the company first disclosed the existence of the above-mentioned long-term transfer and other forms of guarantee commitments, and it was not until April 30, 2021 that the amount of the above-mentioned guarantee commitment contract was disclosed in the 2020 annual report. The above behavior does not comply with the third item of Article 32 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.21 [2014]) and the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.24 [2015] and CSRC Announcement No.31 [2016]) Paragraph 4 of Article 41, Paragraph 3 of Article 29 of Criteria No.3 for Information Disclosure of Companies Offering Securities to the Public-Contents and Format of Semi-annual Reports (Announcement No.22 of CSRC [2014]) and Criteria No.3 for Information Disclosure of Companies Offering Securities to the Public-Contents and Format of Semi-annual Reports.(CSRC Announcement [2016] No.32, CSRC Announcement [2017] No.18) The relevant provisions in Item 3 of Article 39 violate Article 2, Paragraph 1, Article 19, Paragraph 1, Article 21, Item 10, Article 22, Paragraph 7, Article 30, Paragraph 1 and Article 30, Paragraph 2 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.40 of CSRC).

  2. The external guarantee fails to perform the review procedure and is not disclosed as required. In October 2016, your company issued a Letter of Guarantee, stipulating that the insured shall bear irrevocable joint and several liability if he fails to fulfill the transferee obligation as scheduled, involving a guarantee principal of 700 million yuan. In April 2021, the above guarantee obligation was lifted. Your company failed to fulfill the deliberation procedures of the board of directors and the shareholders’ meeting, disclosed it in the interim announcement, and disclosed it in the annual report from 2016 to 2020 and the semi-annual report from 2017 to 2020. The above behavior does not comply with the first and third items of Article 1 of the Notice on Regulating the External Guarantee Behavior of Listed Companies (Zheng Jian Fa [2005] No.120) and the second item of Article 41 of the Standards for the Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.31 [2016] and CSRC Announcement No.17 [2017]). The relevant provisions in Item 2 of Article 39 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.3-Contents and Formats of Semi-annual Reports (Announcement No.32 [2016] of CSRC and Announcement No.18 [2017] of CSRC) violate Article 2, Paragraph 1, Article 19, Paragraph 1 and Article 21, Article 10 of the Administrative Measures for Information Disclosure of Listed Companies (Order No.40 of CSRC).

  3. Major litigation is not disclosed as required. In 2019, as a defendant, your company was involved in litigation for signing an agreement and a contract for the transfer of beneficial rights. However, your company did not disclose the above litigation matters in time, nor did it disclose it in the 2019 semi-annual report, and it was not disclosed until November 16, 2019, December 17, 2019 and April 30, 2020. In 2019, 2020 and January 2021, your company was involved in litigation as a plaintiff. The company did not disclose the above litigation matters in time, nor did it disclose it in the 2019 annual report and the 2019 and 2020 semi-annual reports. It was not until April 30, 2021 that the amount involved in the lawsuit was disclosed in the 2020 annual report. The above behavior does not comply with the relevant provisions of Article 36, paragraph 1, of Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (Announcement No.17 of CSRC) and Article 34, paragraph 1 of Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.3-Contents and Formats of Semi-annual Reports (Announcement No.18 of CSRC). The above acts violate the relevant provisions of Article 2, Paragraph 1, Article 19, Item 10, Article 22, Item 5, Article 30, Paragraph 1 and Article 30, Paragraph 2, Item 10 of the Administrative Measures on Information Disclosure of Listed Companies (Order No.40 of the CSRC).

  4. The main assets are pledged or frozen and not disclosed as required. From 2019 to March 2020, many assets of your company were pledged or frozen. Your company did not disclose the above-mentioned asset restriction in time, nor did it disclose it completely and accurately in the 2019 semi-annual report and annual report. It was not until May 15, 2020 that the asset pledge was frozen in the form of a temporary announcement. The above behavior does not comply with the relevant provisions of Article 27, Item 3 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (Announcement No.17 of CSRC) and Item 3 of Article 26 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.3-Contents and Formats of Semi-annual Reports (Announcement No.18 of CSRC). It violates the relevant provisions of Article 2, Paragraph 1, Article 19, Paragraph 1, Article 21, Item 10, Article 22, Item 7, Article 30, Paragraph 1 and Article 30, Paragraph 2, Item 15 of the Administrative Measures on Information Disclosure of Listed Companies (Order No.40 of the CSRC).

  5. The occupation of non-operating funds by related parties is not disclosed as required. On December 30, 2017, your company issued a trust loan of 500 million yuan through the trust plan. In January 2018, 297 million yuan of the above funds was indirectly transferred to the account of Shanghai Guozhijie Investment Development Co., Ltd., the original controlling shareholder of the company. In December 2018, your company subscribed for part of the above trust plan with an inherent capital of RMB 181.4 million. In April 2021, the company received the above trust share transfer payment. The above acts constitute the related party’s non-operating occupation of your company’s funds, which is inconsistent with the provisions of Article 1, paragraph 2, item 1 of the Notice on Regulating the Capital Exchange between Listed Companies and Related Parties and External Guarantee of Listed Companies (CSRC Announcement [2017] No.16) and Article 70, paragraph 2 of the Corporate Governance Standards for Listed Companies (CSRC Announcement [2018] No.29). Your company did not disclose the non-operating capital occupation of the above related parties in time, nor did it disclose it in the annual reports of 2018, 2019 and 2020 and the semi-annual reports of 2019 and 2020 as required. It does not conform to Articles 2 and 10 of Accounting Standards for Enterprises No.36-Related Party Disclosure (Cai Shui [2006] No.3), Article 52 of Compilation Rules for Information Disclosure of Companies Offering Securities to the Public No.15-General Provisions on Financial Reports (CSRC Announcement No.54 [2014]), and Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents of Annual Reports.Paragraph 1 of Article 31 violates the provisions of Paragraph 1 of Article 2, Paragraph 1 of Article 19, Paragraph 10 of Article 21, Paragraph 7 of Article 22, Paragraph 1 of Article 30, Paragraph 21 of Article 30 and Article 48 of the Administrative Measures for Information Disclosure of Listed Companies (Order No.40 of CSRC).

  According to Item 3 of Article 59 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.40 of the CSRC), we are now taking regulatory measures to issue a warning letter to your company. Your company should actively take effective measures to strengthen corporate governance, improve the quality of information disclosure and enhance the standard operation level.

  If you are not satisfied with this supervision and management measure, you can apply for administrative reconsideration to China Securities Regulatory Commission within 60 days from the date of receiving this decision, or you can bring a lawsuit to the people’s court with jurisdiction within 6 months from the date of receiving this decision. During the period of reconsideration and litigation, the above supervision and management measures shall not be suspended.

  Decision on Taking Measures to Issue Warning Letter to Wang Shaoqin (No.224 [2023] of Shanghai Securities Regulatory Commission)

  Wang Shaoqin:

  Upon investigation, Jianyuan Trust Co., Ltd. (formerly Anxin Trust Co., Ltd., hereinafter referred to as "Anxin Trust" or "Company") has the following problems:

  1. Major contracts are not disclosed as required. Since 2014, in the process of conducting trust business, the company has signed trust beneficial right transfer agreements, beneficial right transfer contracts and business cooperation agreements with some trust beneficiaries. The company did not disclose it in time in the interim announcement, nor did it disclose it in the annual report from 2015 to 2018 and the semi-annual report from 2015 to 2019. It was not until November 12, 2019 that the company first disclosed the existence of the above-mentioned long-term transfer and other forms of guarantee commitment in the reply announcement to the exchange inquiry letter, and it was not until April 30, 2021 that the amount of the above-mentioned guarantee commitment contract was disclosed in the 2020 annual report. The above behavior does not comply with the third item of Article 32 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.21 [2014]) and the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.24 [2015] and CSRC Announcement No.31 [2016]) Paragraph 4 of Article 41, Paragraph 3 of Article 29 of Criteria No.3 for Information Disclosure of Companies Offering Securities to the Public-Contents and Format of Semi-annual Reports (Announcement No.22 of CSRC [2014]) and Criteria No.3 for Information Disclosure of Companies Offering Securities to the Public-Contents and Format of Semi-annual Reports.(CSRC Announcement [2016] No.32, CSRC Announcement [2017] No.18) The relevant provisions in Item 3 of Article 39 violate Article 2, Paragraph 1, Article 19, Paragraph 1, Article 21, Item 10, Article 22, Paragraph 7, Article 30, Paragraph 1 and Article 30, Paragraph 2 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.40 of CSRC).

  2. The external guarantee fails to perform the review procedure and is not disclosed as required. In October 2016, the company issued a Letter of Guarantee, stipulating that the insured shall bear irrevocable joint and several liability if he fails to fulfill the transferee obligation as scheduled, involving a guarantee principal of 700 million yuan. In April 2021, the above guarantee obligation was lifted. The company did not perform the deliberation procedures of the board of directors and shareholders’ meeting on this matter, and it was not disclosed in the interim announcement, nor in the annual report from 2016 to 2020 and the semi-annual report from 2017 to 2020. The above behavior does not comply with the first and third items of Article 1 of the Notice on Regulating the External Guarantee Behavior of Listed Companies (Zheng Jian Fa [2005] No.120) and the second item of Article 41 of the Standards for the Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.31 [2016] and CSRC Announcement No.17 [2017]). The relevant provisions in Item 2 of Article 39 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.3-Contents and Formats of Semi-annual Reports (Announcement No.32 [2016] of CSRC and Announcement No.18 [2017] of CSRC) violate Article 2, Paragraph 1, Article 19, Paragraph 1 and Article 21, Article 10 of the Administrative Measures for Information Disclosure of Listed Companies (Order No.40 of CSRC).

  3. The occupation of non-operating funds by related parties is not disclosed as required. On December 30, 2017, the company issued a trust loan of 500 million yuan through the trust plan. In January 2018, 297 million yuan of the above funds was indirectly transferred to the account of Shanghai Guozhijie Investment Development Co., Ltd., the original controlling shareholder of the company. In December 2018, the company subscribed for part of the above trust plan with an inherent capital of 181.4 million yuan. In April 2021, the company received the above trust share transfer payment. The above acts constitute the related party’s non-operating occupation of the company’s funds, which is inconsistent with the provisions of Article 1, paragraph 2, item 1 of the Notice on Regulating the Capital Exchange between Listed Companies and Related Parties and External Guarantee of Listed Companies (CSRC Announcement [2017] No.16) and Article 70, paragraph 2 of the Corporate Governance Standards for Listed Companies (CSRC Announcement [2018] No.29). The company did not disclose the non-operating capital occupation of the above related parties in time, nor did it disclose it in the annual reports of 2018, 2019 and 2020 and the semi-annual reports of 2019 and 2020 as required. It does not conform to Articles 2 and 10 of Accounting Standards for Enterprises No.36-Related Party Disclosure (Cai Shui [2006] No.3), Article 52 of Compilation Rules for Information Disclosure of Companies Offering Securities to the Public No.15-General Provisions on Financial Reports (CSRC Announcement No.54 [2014]), and Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-the contents of annual reports.Paragraph 1 of Article 31 violates the provisions of Paragraph 1 of Article 2, Paragraph 1 of Article 19, Paragraph 10 of Article 21, Paragraph 7 of Article 22, Paragraph 1 of Article 30, Paragraph 21 of Article 30 and Article 48 of the Administrative Measures for Information Disclosure of Listed Companies (Order No.40 of CSRC).

  You (IDNo.: 410 * * * * * * * * *), as the chairman of Anxin Trust from November 2012 to May 2019, failed to perform your duties diligently and was responsible for the above matters of the company, which violated Articles 3, 38 and 40 of the Administrative Measures on Information Disclosure of Listed Companies (Order No.40 of the CSRC).

  According to Article 58 and Item 3 of Article 59 of the Measures for the Administration of Information Disclosure of Listed Companies, our bureau has decided to issue a warning letter to you.

  If you are not satisfied with this supervision and management measure, you can apply for administrative reconsideration to China Securities Regulatory Commission within 60 days from the date of receiving this decision, or you can bring a lawsuit to the people’s court with jurisdiction within 6 months from the date of receiving this decision. During the period of reconsideration and litigation, the above supervision and management measures shall not be suspended.

  Decision on Taking Measures to Issue Warning Letters to Yang Xiaobo (No.225 [2023] of Shanghai Securities Regulatory Commission)

  Yang Xiaobo:

  Upon investigation, Jianyuan Trust Co., Ltd. (formerly Anxin Trust Co., Ltd., hereinafter referred to as "Anxin Trust" or "Company") has the following problems:

  1. Major contracts are not disclosed as required. Since 2014, in the process of conducting trust business, the company has signed trust beneficial right transfer agreements, beneficial right transfer contracts and business cooperation agreements with some trust beneficiaries. The company did not disclose it in time in the interim announcement, nor did it disclose it in the annual report from 2015 to 2018 and the semi-annual report from 2015 to 2019. It was not until November 12, 2019 that the company first disclosed the existence of the above-mentioned long-term transfer and other forms of guarantee commitment in the reply announcement to the exchange inquiry letter, and it was not until April 30, 2021 that the amount of the above-mentioned guarantee commitment contract was disclosed in the 2020 annual report. The above behavior does not comply with the third item of Article 32 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.21 [2014]) and the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.24 [2015] and CSRC Announcement No.31 [2016]) Paragraph 4 of Article 41, Paragraph 3 of Article 29 of Criteria No.3 for Information Disclosure of Companies Offering Securities to the Public-Contents and Format of Semi-annual Reports (Announcement No.22 of CSRC [2014]) and Criteria No.3 for Information Disclosure of Companies Offering Securities to the Public-Contents and Format of Semi-annual Reports.(CSRC Announcement [2016] No.32, CSRC Announcement [2017] No.18) The relevant provisions in Item 3 of Article 39 violate Article 2, Paragraph 1, Article 19, Paragraph 1, Article 21, Item 10, Article 22, Paragraph 7, Article 30, Paragraph 1 and Article 30, Paragraph 2 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.40 of CSRC).

  2. The external guarantee fails to perform the review procedure and is not disclosed as required. In October 2016, the company issued a Letter of Guarantee, stipulating that the insured shall bear irrevocable joint and several liability if he fails to fulfill the transferee obligation as scheduled, involving a guarantee principal of 700 million yuan. In April 2021, the above guarantee obligation was lifted. The company did not perform the deliberation procedures of the board of directors and shareholders’ meeting on this matter, and it was not disclosed in the interim announcement, nor in the annual report from 2016 to 2020 and the semi-annual report from 2017 to 2020. The above behavior does not comply with the first and third items of Article 1 of the Notice on Regulating the External Guarantee Behavior of Listed Companies (Zheng Jian Fa [2005] No.120) and the second item of Article 41 of the Standards for the Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.31 [2016] and CSRC Announcement No.17 [2017]). The relevant provisions in Item 2 of Article 39 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.3-Contents and Formats of Semi-annual Reports (Announcement No.32 [2016] of CSRC and Announcement No.18 [2017] of CSRC) violate Article 2, Paragraph 1, Article 19, Paragraph 1 and Article 21, Article 10 of the Administrative Measures for Information Disclosure of Listed Companies (Order No.40 of CSRC).

  You (ID number: 310 * * * * * * * * *), as the president of Anxin Trust from November 2012 to October 2018, failed to perform your duties diligently and were responsible for the above-mentioned matters of the company, which violated Articles 3, 38 and 30 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.40 of the CSRC).

  According to Article 58 and Item 3 of Article 59 of the Measures for the Administration of Information Disclosure of Listed Companies, our bureau has decided to issue a warning letter to you.

  If you are not satisfied with this supervision and management measure, you can apply for administrative reconsideration to China Securities Regulatory Commission within 60 days from the date of receiving this decision, or you can bring a lawsuit to the people’s court with jurisdiction within 6 months from the date of receiving this decision. During the period of reconsideration and litigation, the above supervision and management measures shall not be suspended.

  Decision on Taking Measures to Issue Warning Letters to Shao Mingan (No.226 [2023] of Shanghai Securities Regulatory Commission)

  Shao Mingan:

  Upon investigation, Jianyuan Trust Co., Ltd. (formerly Anxin Trust Co., Ltd., hereinafter referred to as "Anxin Trust" or "Company") has the following problems:

  1. Major contracts are not disclosed as required. Since 2014, in the process of conducting trust business, the company has signed trust beneficial right transfer agreements, beneficial right transfer contracts and business cooperation agreements with some trust beneficiaries. The company did not disclose it in time in the interim announcement, nor did it disclose it in the annual report from 2015 to 2018 and the semi-annual report from 2015 to 2019. It was not until November 12, 2019 that the company first disclosed the existence of the above-mentioned long-term transfer and other forms of guarantee commitment in the reply announcement to the exchange inquiry letter, and it was not until April 30, 2021 that the amount of the above-mentioned guarantee commitment contract was disclosed in the 2020 annual report. The above behavior does not comply with the third item of Article 32 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.21 [2014]) and the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.24 [2015] and CSRC Announcement No.31 [2016]) Paragraph 4 of Article 41, Paragraph 3 of Article 29 of Criteria No.3 for Information Disclosure of Companies Offering Securities to the Public-Contents and Format of Semi-annual Reports (Announcement No.22 of CSRC [2014]) and Criteria No.3 for Information Disclosure of Companies Offering Securities to the Public-Contents and Format of Semi-annual Reports.(CSRC Announcement [2016] No.32, CSRC Announcement [2017] No.18) The relevant provisions in Item 3 of Article 39 violate Article 2, Paragraph 1, Article 19, Paragraph 1, Article 21, Item 10, Article 22, Paragraph 7, Article 30, Paragraph 1 and Article 30, Paragraph 2 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.40 of CSRC).

  2. The external guarantee fails to perform the review procedure and is not disclosed as required. In October 2016, the company issued a Letter of Guarantee, stipulating that the insured shall bear irrevocable joint and several liability if he fails to fulfill the transferee obligation as scheduled, involving a guarantee principal of 700 million yuan. In April 2021, the above guarantee obligation was lifted. The company did not perform the deliberation procedures of the board of directors and shareholders’ meeting on this matter, and it was not disclosed in the interim announcement, nor in the annual report from 2016 to 2020 and the semi-annual report from 2017 to 2020. The above behavior does not comply with the first and third items of Article 1 of the Notice on Regulating the External Guarantee Behavior of Listed Companies (Zheng Jian Fa [2005] No.120) and the second item of Article 41 of the Standards for the Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (CSRC Announcement No.31 [2016] and CSRC Announcement No.17 [2017]). The relevant provisions in Item 2 of Article 39 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.3-Contents and Formats of Semi-annual Reports (Announcement No.32 [2016] of CSRC and Announcement No.18 [2017] of CSRC) violate Article 2, Paragraph 1, Article 19, Paragraph 1 and Article 21, Article 10 of the Administrative Measures for Information Disclosure of Listed Companies (Order No.40 of CSRC).

  3. Major litigation is not disclosed as required. In 2019, as a defendant, the company was involved in litigation because of signing an agreement on the transfer of beneficial rights and a contract for the transfer of beneficial rights. However, the company did not disclose the above litigation matters in time, nor did it disclose it in the 2019 semi-annual report, and it was not disclosed until November 16, 2019, December 17, 2019 and April 30, 2020. In 2019, 2020 and January 2021, the company was involved as a plaintiff. The company did not disclose the above litigation matters in time, nor did it disclose it in the 2019 annual report and the 2019 and 2020 semi-annual reports. It was not until April 30, 2021 that the amount involved in the lawsuit was disclosed in the 2020 annual report. The above behavior does not comply with the relevant provisions of Article 36, paragraph 1, of Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (Announcement No.17 of CSRC) and Article 34, paragraph 1 of Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.3-Contents and Formats of Semi-annual Reports (Announcement No.18 of CSRC). The above acts violate the relevant provisions of Article 2, Paragraph 1, Article 19, Item 10, Article 22, Item 5, Article 30, Paragraph 1 and Article 30, Paragraph 2, Item 10 of the Administrative Measures on Information Disclosure of Listed Companies (Order No.40 of the CSRC).

  4. The main assets are pledged or frozen and not disclosed as required. From 2019 to March 2020, many assets of the company were pledged or frozen. The company did not disclose the above-mentioned asset restrictions in time, nor did it disclose them completely and accurately in the 2019 semi-annual report and annual report. It was not until May 15, 2020 that the assets pledge was frozen in the form of a temporary announcement. The above behavior does not comply with the relevant provisions of Article 27, Item 3 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents and Formats of Annual Reports (Announcement No.17 of CSRC) and Item 3 of Article 26 of the Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.3-Contents and Formats of Semi-annual Reports (Announcement No.18 of CSRC). It violates the relevant provisions of Article 2, Paragraph 1, Article 19, Paragraph 1, Article 21, Item 10, Article 22, Item 7, Article 30, Paragraph 1 and Article 30, Paragraph 2, Item 15 of the Administrative Measures on Information Disclosure of Listed Companies (Order No.40 of the CSRC).

  5. The occupation of non-operating funds by related parties is not disclosed as required. On December 30, 2017, the company issued a trust loan of 500 million yuan through the trust plan. In January 2018, 297 million yuan of the above funds was indirectly transferred to the account of Shanghai Guozhijie Investment Development Co., Ltd., the original controlling shareholder of the company. In December 2018, the company subscribed for part of the above trust plan with an inherent capital of 181.4 million yuan. In April 2021, the company received the above trust share transfer payment. The above acts constitute the related party’s non-operating occupation of the company’s funds, which is inconsistent with the provisions of Article 1, paragraph 2, item 1 of the Notice on Regulating the Capital Exchange between Listed Companies and Related Parties and External Guarantee of Listed Companies (CSRC Announcement [2017] No.16) and Article 70, paragraph 2 of the Corporate Governance Standards for Listed Companies (CSRC Announcement [2018] No.29). The company did not disclose the non-operating capital occupation of the above related parties in time, nor did it disclose it in the annual reports of 2018, 2019 and 2020 and the semi-annual reports of 2019 and 2020 as required. It does not conform to Articles 2 and 10 of Accounting Standards for Enterprises No.36-Related Party Disclosure (Cai Shui [2006] No.3), Article 52 of Compilation Rules for Information Disclosure of Companies Offering Securities to the Public No.15-General Provisions on Financial Reports (CSRC Announcement No.54 [2014]), and Standards for Contents and Formats of Information Disclosure of Companies Offering Securities to the Public No.2-Contents of Annual Reports.Paragraph 1 of Article 31 violates the provisions of Paragraph 1 of Article 2, Paragraph 1 of Article 19, Paragraph 10 of Article 21, Paragraph 7 of Article 22, Paragraph 1 of Article 30, Paragraph 21 of Article 30 and Article 48 of the Administrative Measures for Information Disclosure of Listed Companies (Order No.40 of CSRC).

  You (ID number: 210 * * * * * * * * * *) served as a director of Essence Trust from November 2012 to September 2022, performed the duties of chairman from July 2019 to January 2020, and performed the duties of president from October 2018 to April 2019, and failed to perform your duties diligently.

  According to Article 58 and Item 3 of Article 59 of the Measures for the Administration of Information Disclosure of Listed Companies, our bureau has decided to issue a warning letter to you.

  If you are not satisfied with this supervision and management measure, you can apply for administrative reconsideration to China Securities Regulatory Commission within 60 days from the date of receiving this decision, or you can bring a lawsuit to the people’s court with jurisdiction within 6 months from the date of receiving this decision. During the period of reconsideration and litigation, the above supervision and management measures shall not be suspended.

  Changsha Bank’s 1.953 billion restricted shares will be listed and circulated on September 26th.

  () Announcement, the total number of shares listed and circulated by the company this time is 1.953 billion shares, and the date of listing and circulation is September 26, 2023.

  Sinopharm Modern: The application for listing lidocaine hydrochloride was approved.

  Sinopharm Modern announced that Sinopharm Hasen, a holding subsidiary of the company, received the Notice of Approval for the Listing Application of Chemical Raw Materials for Lidocaine Hydrochloride approved and issued by National Medical Products Administration. Lidocaine hydrochloride is a local anesthetic and antiarrhythmic drug, which is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block. It can also be used for ventricular premature contraction and ventricular tachycardia after acute myocardial infarction, digitalis poisoning, cardiac surgery and ventricular arrhythmia caused by cardiac catheter.

  About 1.457 billion restricted shares of Zhonggu Logistics will be listed and circulated on September 25th.

  () Announced that the number of restricted shares listed and circulated this time is about 1.457 billion shares, accounting for 69.38% of the company’s total share capital, and the listing and circulation date is September 25, 2023.

  Taijing Technology repurchased 3,913,500 shares at a cost of 63,113,500 yuan.

  () Announcement: As of September 18, 2023, the company has repurchased 3,913,500 shares of the company by centralized bidding, accounting for 1.0052% of the company’s total share capital, and the total amount paid is 63,113,500 yuan (excluding transaction costs).

  (): signed a cooperation agreement with Fanchang District People’s Government of Wuhu City and () Green Advanced Materials Research Institute.

  Tianchen Co., Ltd. announced on the evening of September 18th that it had signed a Cooperation Agreement with the People’s Government of Fanchang District of Wuhu City and China Nengjian Green Advanced Materials Research Institute, which included the research and development and transformation of positive and negative materials in new lithium battery. Research on energy storage industry standard system: Research and development and industrial application of new energy storage materials and batteries such as cement batteries.

  Tianchen shares: signed cooperation agreements with Fanchang District People’s Government of Wuhu City and China Nengjian Green Advanced Materials Research Institute.

  Tianchen Co., Ltd. announced on the evening of September 18th that it had signed a Cooperation Agreement with the People’s Government of Fanchang District of Wuhu City and China Nengjian Green Advanced Materials Research Institute, which included the research and development and transformation of positive and negative materials in new lithium battery. Research on energy storage industry standard system: Research and development and industrial application of new energy storage materials and batteries such as cement batteries.

  Measures to stabilize the stock price of electric wind power: Some directors of Jiangao plan to increase their shares by 345,500 yuan to 691,100 yuan.

  Electric Wind Power announced that according to the company’s Stock Price Stability Plan, the company will adopt measures to increase the company’s shares by directors and senior managers who meet the conditions stipulated in the Stock Price Stability Plan to stabilize the stock price. At the same time, based on confidence in the future development of the company, other directors, supervisors and senior managers who are currently working in the company and receiving salaries also voluntarily increase their holdings of the company’s shares.

  There are 8 directors, senior managers, and directors, supervisors and senior managers who meet the requirements specified in the Stock Price Stability Plan. The planned cumulative increase in shares is not less than 5% of the total after-tax remuneration of the previous year, and the maximum is not more than 10% of the total after-tax remuneration of the previous year, that is, the total is not less than 345,500 yuan, and the maximum is not more than 691,100 yuan. The price of the increased shares does not exceed the audited net assets per share of the company at the end of the latest period.

  About 6,723,200 restricted shares of Saiwei Power will be listed and circulated on September 27th.

  Saiweidian announced that the number of shares that have been released from the restricted sale and applied for listing and circulation is about 6,723,200 shares, accounting for 8.0681% of the company’s total share capital, and will be listed and circulated on September 27, 2023.

  Antai Group: Since 2023, the gross profit of the company’s main products has decreased significantly.

  () Announcement: Since September 13th, 2023, the share price of the company has increased greatly, but the company’s fundamentals have not changed significantly.

  According to the announcement, the company’s operating performance in the last year and the first phase has suffered a large loss. In 2022, the company’s net profit attributable to shareholders of listed companies was-297 million yuan, and in the first half of 2023, the company’s net profit attributable to shareholders of listed companies was-273 million yuan, with a large year-on-year loss. There is uncertainty about the overall profitability of the industry in the future. Since 2023, the downstream demand of steel and coking industries has recovered less than expected, and the product price has fluctuated at a low level, while the decline in the purchase price of main raw materials is less than the decline in the sales price of products, resulting in a significant decrease in the gross profit of the company’s main products.

  Jinhui shares will be sent to 0.3 yuan and date of record every half year on September 25th.

  () It is announced that the company will distribute the equity in the first half of 2023, and each share will be distributed with cash dividends (including tax) in 0.3 yuan and date of record on September 25th.

  Electric wind power: the controlling shareholder intends to increase the company’s shares by 1%-2%.

  Electric Wind Power announced on the evening of September 18th that the controlling shareholder () intends to increase its shareholding in the Company, and the number of shares it plans to increase cumulatively shall not be less than 1% of the total shares of the Company, and the maximum shall not exceed 2% of the total shares of the Company; There are 8 directors and supervisors in the company, and it is planned to increase the company’s shares cumulatively, with a total amount of not less than 345,500 yuan and a maximum of 691,100 yuan.

  Electric wind power: the controlling shareholder intends to increase the company’s shares by 1%-2%.

  On the evening of September 18th, Electric Wind Power announced that Shanghai Electric, the controlling shareholder, intends to increase its shareholding in the Company, and the number of shares it plans to increase cumulatively shall not be less than 1% of the total shares of the Company, and the maximum shall not exceed 2% of the total shares of the Company; There are 8 directors and supervisors in the company, and it is planned to increase the company’s shares cumulatively, with a total amount of not less than 345,500 yuan and a maximum of 691,100 yuan.

  Zejing Pharmaceutical: Phase III clinical trial of recombinant human thyrotropin for injection reached the preset main end point.

  Zejing Pharmaceutical announced that the Phase III clinical trial of recombinant human thyroid stimulating hormone (rhTSH) for injection independently developed by the company, "An open, single-arm, self-controlled, multi-center Phase III clinical study on the effectiveness and safety of recombinant human thyroid stimulating hormone (rhTSH) compared with thyroid hormone therapy for postoperative auxiliary diagnosis of patients with differentiated thyroid cancer" reached the main end point of the scheme. The company will submit a communication application for Pre-BLA (listing application for new biological drugs) to National Medical Products Administration Drug Evaluation Center (CDE) to promote the listing process of recombinant human thyrotropin for injection. Detailed data about this study will be published at international or domestic clinical academic conferences.

  HNA Holdings’ passenger traffic in August increased by 154.33% year-on-year.

  () Announced that in August 2023, the Group introduced a B737-800 aircraft and withdrew an A350-900 aircraft. By the end of August 2023, the Group had operated a total of 339 aircraft. In August, 2023, the group’s revenue per kilometer increased by 2.97% month-on-month and 195.47% year-on-year. Passenger traffic increased by 3.36% from the previous month and 154.33% from the same period last year. Investment in passenger transport capacity (in terms of available passenger kilometers) increased by 2.13% month-on-month and 140.11% year-on-year.

  HNA Holdings: signed a memorandum of cooperation with Aguiran and Yangpu Economic Development Zone Management Committee.

  On the evening of September 18th, HNA Holdings announced that it had signed a memorandum of cooperation with Aguiran and Yangpu Economic Development Zone Management Committee, and all partners planned to jointly explore the construction of a green and low-carbon chemical joint venture in Yangpu Economic Development Zone, Hainan Province, and strive to build a benchmark project for economic and trade cooperation between China and Saudi Arabia. In addition, in August, the group’s passenger kilometers increased by 2.97% month-on-month and 195.47% year-on-year; Passenger traffic increased by 3.36% from the previous month and 154.33% from the same period last year. Investment in passenger transport capacity (in terms of available passenger kilometers) increased by 2.13% month-on-month and 140.11% year-on-year.

  HNA Holdings plans to build a green and low-carbon chemical joint venture with Saudi Aguiran in Yangpu Economic Development Zone, Hainan.

  HNA Holdings announced that on September 15, 2023, the company signed a memorandum of cooperation with Aguiran Brothers Holding Group Company of Saudi Arabia (hereinafter referred to as "Aguiran") and Yangpu Economic Development Zone Management Committee of Hainan Province (hereinafter referred to as "Yangpu Economic Development Zone Management Committee"). With the help of Saudi Arabia’s rich oil reserves and the local influence of Aguiran Brothers Holding Group Company, relying on HNA Holdings’ huge and growing demand for aviation kerosene, Give full play to the land, shipping and policy advantages of Hainan Free Trade Port and Yangpu Economic Development Zone, take green environmental protection as the investment premise, take system automation+international new technology+deep processing of products+high output efficiency as the industrial core, and all partners will jointly explore the investment and construction of a green and low-carbon chemical joint venture in Yangpu Economic Development Zone, Hainan, and strive to build a benchmark project for economic and trade cooperation between China and Saudi Arabia.

  The signing of this cooperation memorandum is in line with the company’s development strategy. If the relevant cooperation projects can be finally reached, it will help the company explore new profit growth points and save operating costs, which will have a certain positive effect on the company’s long-term operation and performance.

  Naxinwei granted 3.8 million restricted shares to 292 incentive targets.

  Naxinwei announced that the company decided September 18th, 2023 as the grant date, and granted 3.8 million restricted shares to 292 incentive targets at the grant price of 49 yuan per share.

  Jinhui shares will send 3 yuan date of record for every 10 shares in the first half of 2023 as September 25th.

  Jinhui Co., Ltd. announced that the company’s half-year equity distribution implementation plan for 2023 is as follows: based on the total share capital of 978 million shares, a cash dividend of 3.00 yuan will be distributed to all shareholders for every 10 shares, with a total cash dividend of 293 million yuan, accounting for 192.69% of the net profit attributable to the mother in the same period. No bonus shares will be distributed and no capital reserve will be converted into share capital.

  The distribution of rights and interests in date of record is September 25th, and the ex-dividend date is September 26th.

  According to the 2023 semi-annual performance report released by Jinhui Co., Ltd., the company’s operating income was 549 million yuan, down 12.87% year-on-year; The net profit attributable to shareholders of listed companies was 152 million yuan, a year-on-year decrease of 36.74%; The basic earnings per share was 0.16 yuan, compared with 0.25 yuan in the same period last year.

  The main business of Jinhui Mining Co., Ltd. is the mining and trading of non-ferrous metals. The company’s main products are zinc concentrate and lead concentrate (including silver). The company has been rated as the first batch of green factories, national green mines and national high-tech enterprises in China, won the first outstanding contribution award of green mines, the first prize of national green mine science and technology major projects, and the first prize of the seventh China nonferrous metal geological prospecting achievement. Zhongguancun Green Mine Industry Alliance awarded the company the "Top 20 National Green Mines with High Quality Development in 2020", and it is one of the top ten leading enterprises in the green development of nonferrous metals industry and a national green mine model enterprise established by the Ministry of Natural Resources.

  (Source: () iFinD)

  Shangsheng Electronics: Wu Yuwei and Bai Guangmei resigned as executive managers.

  Shangsheng Electronics announced that the board of directors of the company recently received a report from the company that Wu Yuwei and Bai Guangmei, executive managers of the company, had reached retirement age and resigned as executive managers of the company. After their departure, Wu Yuwei and Bai Guangmei will be appointed as senior consultants by the company, and their withdrawal from their original positions will not adversely affect the daily production and operation of the company.

  The exercise price of 1 million stock options granted by Chaoxun Communication is 12.6 yuan/share.

  () Announcement: The reserved grant conditions of stock options stipulated in the Company’s 2022 Stock Option Incentive Plan have been achieved, and the Board of Directors agreed to grant 1 million stock options to two incentive targets on September 18, 2023, with the exercise price of 12.60 yuan/share.

  Xi ‘an Bank: Vice President Di Hao slightly increased his shareholding in the company.

  Xi ‘an Bank announced that Di Hao, vice president of the company, increased his holding of 216,500 shares from September 15th to September 18th, 2023, accounting for 0.0049% of the company’s total share capital. The overweight price range is 3.57-3.65 yuan/share. Di Hao promises that the above-mentioned purchased shares will not be reduced within three years from the date of purchase.

  China Holding Co., Ltd. intends to acquire 51% equity of China Holding Green to integrate its technology and technical products.

  () Announced that the company intends to take over 20.72%, 23.67% and 3.97% of China Green held by Li Caibin, China Green (Beijing) Environmental Development Co., Ltd. (China Green), Zhang Xiaohui and Peng Guangxia (hereinafter collectively referred to as the Transferor) in cash. The final price of this transaction is determined to be 43.2641 million yuan. After the transaction is completed, the company will hold 51% equity of China Green, and China Green will become a holding subsidiary of the company.

  After the acquisition of the controlling stake in China Green, the company will integrate the technology and technical products of China Green, sort out the market and sales channels of China Green, realize the coordinated development in the business field of comprehensive organic waste treatment and utilization, further enhance the company’s technical strength and competitiveness in the business field of comprehensive organic waste treatment and utilization, and is expected to effectively enhance the company’s profitability.

  China Holding Shares: 51% of the shares of China Holding Green are to be acquired.

  On the evening of September 18th, China Holdings announced that the company intends to transfer 20.72%, 23.67%, 3.97% and 2.64% of the shares of China Holdings Green held by Li Caibin, China Holdings Environmental Protection, Zhang Xiaohui and Peng Guangxia respectively in cash. The final price of this transaction is determined to be 43.2641 million yuan. After the transaction is completed, the company will hold a 51% stake in China Green. After the acquisition of the controlling stake in China Green, the company will integrate the technology and technical products of China Green, sort out the market and sales channels of China Green, realize the coordinated development in the business field of comprehensive organic waste treatment and utilization, and further enhance the technical strength and competitiveness of the company in the business field of comprehensive organic waste treatment and utilization.

  Jianfeng Group: Mycophenolate mofetil capsules passed the conformity evaluation of generic drugs.

  Jianfeng Group announced that its wholly-owned subsidiary, Jianfeng Pharmaceutical Co., Ltd., received the Notice of Approval for Supplementary Application of Mycophenolate mofetil Capsules from National Medical Products Administration, which indicated that the drug had passed the consistency evaluation of generic drug quality and efficacy. This product is suitable for the induction treatment and maintenance treatment of III-V adult lupus nephritis patients. Mycophenolate mofetil capsules have been listed in the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2022) and classified as Class B; It has been listed in the National Essential Drugs Catalogue (2018 Edition).

  Electric wind power: the controlling shareholder and Dong Jiangao’s staff intend to increase their shares in the company.

  Electric Wind Power announced that Shanghai Electric, the controlling shareholder of the company, plans to increase its holdings of the company’s shares. The cumulative number of shares to be increased is not less than 1% of the company’s total shares, and the maximum is not more than 2% of the company’s total shares. The increase price does not exceed the company’s audited net assets per share at the end of the latest period (the audited net assets per share of the company by the end of 2022 is 5.36 yuan/share).

  On the same day, the company announced that it would take measures to stabilize the stock price by increasing the shares of the company by directors and senior managers who meet the requirements stipulated in the Stock Price Stability Plan. There are 8 directors, senior managers and directors, supervisors and senior managers who meet the relevant requirements this time. The planned cumulative shareholding increase is not less than 345,500 yuan, and the maximum shareholding increase is not more than 691,100 yuan. The shareholding increase price does not exceed the audited net assets per share of the company at the end of the latest period (the audited net assets per share of the company by the end of 2022 is 536 yuan/share).

  Yishitong plans to build a solid oxide energy system project with an annual output of 1GW to realize the industrialization of SOC research projects.

  Yishitong announced that the company intends to invest and build a solid oxide energy system project with an annual output of 1GW in Hefei High-tech Zone with Anhui Yishitong Materials Science Research Institute Co., Ltd. (referred to as "Yishitong Research Institute") as the main body of implementation. The company intends to negotiate and adjust some terms of the original cooperation agreement and the original supplementary agreement signed with the investment promotion center of Hefei High-tech Zone in November 2019, and sign a new supplementary agreement on key materials of Yishitong 5G communication and investment cooperation of Hefei headquarters base project (II).

  The project plot is planned to be located at the northeast corner of the intersection of General Mountain Road and Xianghongdian Road in Hefei High-tech Zone, with an area of about 66,300 m2 and a planned total construction area of about 158,500 m2. After the project is completed, the production scale of solid oxide energy system with an annual output of 1GW will be formed, including solid oxide fuel cells (SOFC) and solid oxide electrolytic cells (SOEC). It is estimated that the total investment of the project is about 1.211 billion yuan, of which the investment in fixed assets is about 766 million yuan.

  The announcement shows that after the completion of this project, the production scale of solid oxide energy system with an annual output of 1GW will be formed, including solid oxide fuel cell (SOFC) and solid oxide electrolytic cell (SOEC) products, which will realize the industrialization of the company’s SOC research projects and help the company to continuously launch SOC products with high efficiency, low cost and long life.

  The 1,431,400 restricted shares of Shouyao Holdings will be listed and circulated on September 27th.

  Shouyao Holdings announced that the number of restricted shares in the company’s listing and circulation this time was 1,431,400 shares, accounting for 0.9625% of the company’s total share capital, and the listing and circulation date was September 27, 2023.

  Yishitong: It is planned to invest about 1.211 billion yuan to build a solid oxide energy system project.

  Yishitong announced on the evening of September 18th that the company plans to invest and build a solid oxide energy system project with an annual output of 1GW in Hefei High-tech Zone with Yishitong Research Institute as the main body. It is estimated that the total investment of the project is about 1.211 billion yuan.

  Cyrus: At present, the company’s production and operation conditions are normal, and no major changes have taken place.

  () On the evening of September 18th, a change announcement was issued, and AITO asked the new M7 to be listed and delivered, which caused some media attention and heated discussion. In addition, the company has not found any media reports or market rumors that may have a great impact on the company’s stock trading price. The company has no significant information that should be disclosed but not disclosed; The company’s production and operation conditions are normal, and no major changes have taken place.

  The controlling shareholder of Shanghai Yangpu transferred 527,500 convertible bonds along Yangpu in total.

  () Announcement was issued. On September 18, 2023, the company received Zhou Jianqing’s notice. During the period from June 20 to September 18, 2023, it transferred a total of 527,500 convertible bonds along Yangpu through block transactions, accounting for 13.74% of the total convertible bonds issued. After this transfer, Zhou Jianqing, the controlling shareholder and actual controller, held 946,820 convertible bonds along Yangpu, accounting for 24.66% of the total issuance.

  Di Hao, vice president of Xi ‘an Bank, increased the holding of 216,500 shares of the bank.

  On September 18th, Xi ‘an Bank announced that, based on the recognition of the confidence and growth value of the bank’s future development prospects, Di Hao, the bank’s vice president, increased his holding of 216,500 shares of the bank from September 15th to September 18th with his own funds, accounting for 0.0049% of the total share capital, and the holding price range was 3.57-3.65 yuan/share.

  According to the announcement, Di Hao held 12,400 shares before this increase and 228,900 shares after this increase, accounting for 0.0052% of the bank’s total share capital.

  Cyrus: AITO asked the world about the listing of the new M7, which caused a heated discussion.

  Cyrus announced that the deviation of the daily closing price increase of the company’s stock price reached 20% in three consecutive trading days on September 14th, 15th and 18th, 2023, which was an abnormal fluctuation of stock trading. According to the announcement, AITO asked the new M7 to go public and start delivery, which caused some media attention and heated discussion. In addition, the company has not found any media reports or market rumors that may have a great impact on the company’s stock trading price.

  Furi Electronics: Zhongnuo Communication, a subsidiary, did not provide OEM service for Huawei’s Mate 60 series mobile phones.

  () Announced the stock price change announcement, saying that up to now, the subsidiary Shenzhen Zhongnuo Communication Co., Ltd. (hereinafter referred to as "Zhongnuo Communication") has not provided OEM services for Huawei’s Mate60 series mobile phones. Investors are advised to invest rationally and pay attention to preventing investment risks.

  Furi Electronics: Up to now, Zhongnuo Communication, a subsidiary, has not provided OEM services for Huawei’s Mate60 series mobile phones.

  Furi Electronics announced on the evening of September 18 that as of now, its subsidiary Zhongnuo Communication has not provided OEM services for Huawei’s Mate60 series. According to the company’s self-examination, the company’s daily production and operation activities are all normal at present, and the internal and external business environment and main business have not changed significantly.

  HNA Holdings: signed a memorandum of cooperation with Aguiran and Yangpu Economic Development Zone Management Committee.

  HNA Holdings announced that on September 15th, 2023, HNA Holdings signed a memorandum of cooperation with Aguiran Brothers Holding Group Corporation (hereinafter referred to as "Aguiran") and Yangpu Economic Development Zone Management Committee of Hainan Province (hereinafter referred to as "Yangpu Economic Development Zone Management Committee"), and all partners intend to jointly explore the investment and construction of a green and low-carbon chemical joint venture in Yangpu Economic Development Zone of Hainan Province, and strive to build a benchmark project for economic and trade cooperation between China and Saudi Arabia.

  Yishitong: The subsidiary plans to invest 1.21 billion yuan to build a solid oxide energy system project with an annual output of 1GW.

  Yishitong announced that the company intends to invest and build a solid oxide energy system project with an annual output of 1GW in Hefei High-tech Zone with Yishitong Research Institute, a wholly-owned subsidiary, as the main body of implementation. It is estimated that the total investment of this project is about 1,210.64 million yuan.

  Cyrus: At present, the company’s production and operation are normal.

  Sailis announced the announcement of stock trading changes, and AITO asked the new M7 to go public and start delivery, which caused some media attention and heated discussion. In addition, the company has not found any media reports or market rumors that may have a great impact on the company’s stock trading price. According to the company’s self-inspection, the company’s current production and operation activities are normal and no major changes have taken place.

  () The memorandum of cooperation signed with Dubai Comprehensive Economic Zone Authority involves cross-border e-commerce and overseas warehousing operations.

  Hainan Airport announced that on September 15, 2023, Hainan Airport and Dubai Comprehensive Economic Zone Administration signed a memorandum of cooperation, and the two sides agreed to jointly plan cross-border e-commerce business and overseas warehousing operation business; The two sides agreed to establish a communication mechanism, including introducing mutual understanding, dialogue and discussion of possible cooperation and trade opportunities between companies in the free trade zone; Explore the potential areas of knowledge transfer and exchange in smart city initiatives and other related areas of sustainable development; Focusing on the topics of interest between Hainan Airport and Dubai Comprehensive Economic Zone Authority, the two sides planned and mobilized to invite their respective parties to participate in the joint network seminar.

  Furi Electronics: At present, Zhongnuo Communication, a subsidiary, has not provided OEM services for Huawei’s Mate 60 series mobile phones.

  Furi Electronics announced the change of stock trading. At present, the company’s daily production and operation activities are all normal, and the internal and external business environment and main business have not changed significantly. Up to now, the subsidiary Shenzhen Zhongnuo Communication Co., Ltd. (hereinafter referred to as "Zhongnuo Communication") has not provided OEM services for Huawei’s Mate60 series mobile phones. Investors are advised to invest rationally and pay attention to preventing investment risks.

  HNA Holdings signed a memorandum of cooperation with Aguiran and Yangpu Economic Development Zone Management Committee.

  On September 18th, HNA Holdings announced that it had signed a memorandum of cooperation with Aguiran Brothers Holding Group Corporation (hereinafter referred to as "Aguiran") and Yangpu Economic Development Zone Management Committee of Hainan Province (hereinafter referred to as "Yangpu Economic Development Zone Management Committee"), and all partners planned to jointly explore the investment and construction of a green and low-carbon chemical joint venture in Yangpu Economic Development Zone of Hainan Province, and strive to build a benchmark project for economic and trade cooperation between China and Saudi Arabia.

  The announcement also stated that the cooperation parties agreed that the memorandum of cooperation would be valid for three years from the date of signing, during which the cooperation parties could continue to negotiate cooperation matters. The memorandum of cooperation signed this time is a framework and intentional agreement, without mandatory binding force, and does not impose mandatory binding on specific contents such as the transaction target, transaction amount and transaction quantity.

  HNA’s passenger traffic in August increased by 154.33% year-on-year.

  On September 18th, HNA Holdings announced that in August, the passenger transport capacity investment (in terms of available passenger kilometers) increased by 140.11% year-on-year, the passenger transport volume increased by 154.33% year-on-year, and the passenger load factor was 86.59%.

  Cyrus: The stock price has risen by more than 20% for three consecutive trading days, and the company has not undergone major changes.

  On September 18th, Cyrus announced on the Shanghai Stock Exchange that the deviation of the daily closing price of the company’s stock price has reached 20% in three consecutive trading days on September 14th, 15th and 18th, 2023, which is an abnormal fluctuation of stock trading according to the relevant regulations of Shanghai Stock Exchange. After the company’s self-examination and verification with the controlling shareholder and actual controller, there is no significant information that should be disclosed but not disclosed. In addition, through the company’s self-inspection, the company’s production and operation conditions are normal and no major changes have taken place.

  AITO asked about the listing and delivery of the new M7, which caused some media attention and heated discussion. In addition, the company has not found any media reports or market rumors that may have a great impact on the company’s stock trading price.

  Tianchen shares signed a cooperation agreement on building a joint innovation research institute for new energy storage materials.

  Tianchen Co., Ltd. announced that the company ("Party C") has signed the Project Investment Contract and the Supplementary Project Investment Contract with the People’s Government of Fanchang District, Wuhu City, and the company will invest in the construction of a new energy industrial base integrating light and storage in Fanchang District, Wuhu City (see company announcementNo.: Pro 2023-024 for details). On September 16th, 2023, the Company held an agreement signing ceremony with the People’s Government of Fanchang District, Wuhu City (hereinafter referred to as "Party A") and China Nengjian Green Advanced Materials Research Institute (hereinafter referred to as "Party B") in Wuhu, Anhui Province. Since China Nengjian Green Advanced Materials Research Institute is not yet in industrial and commercial registration, it was signed by the representative of Zhongnengjian Green Building Materials Co., Ltd., and the three parties jointly signed the Cooperation Agreement for Building Zhongneng Jianchian Tianchen New Energy Storage Materials Joint Innovation Research Institute.

  Through friendly negotiation, with the support of Party A, Party B and Party C jointly establish Zhongneng Jianchian Tianchen Energy Storage New Materials Joint Innovation Research Institute to develop the latest energy storage materials, technologies and products, as well as the corresponding industry standard system. The cooperation includes the research and development and transformation of anode and cathode materials in new lithium battery; Research on energy storage industry standard system: Research and development and industrial application of new energy storage materials and batteries such as cement batteries; Development and standard research of photovoltaic-energy storage-assembled building integrated components; Integrated application and development of new energy in transportation facilities and other fields, research and development and transformation of new technologies and materials related to energy storage.

  At the same time, we will pool the resource advantages of all parties, develop related industries, promote the transformation of results and market promotion, build an R&D and industrial chain that integrates the design and installation of raw materials synthesis, new electrodes, batteries, photovoltaic, energy storage and buildings, and promote the cross-border integration, transformation and upgrading of photovoltaic modules, new energy storage, building materials and green building industries.

  The company said that the signatories of this cooperation agreement will give full play to their respective resources and advantages, and strengthen exchanges and discussions in new energy technologies and emerging industries, which will help to enhance the company’s technological research and development strength and market competitiveness in the field of energy storage, and will have a positive impact on the company’s future development.

  Clarify pig breeding assets, and Shanghai Meilin’s subsidiaries carry out equity and debt restructuring.

  On September 18th, () announced that the company’s holding subsidiary Guangming Agriculture and Animal Husbandry and Sun Company Jiangsu Zhongwang had recently received the property right transaction certificate issued by Shanghai United Assets and Equity Exchange, and Guangming Agriculture and Animal Husbandry acquired 30% equity of Jiangsu Zhongwang held by Yuhang Wentou for 44.7743 million yuan. Jiangsu Zhongwang transferred 100% equity and creditor’s rights of Huai ‘an Zhongwang to Yuhang Wentou for nearly 111 million yuan.

  According to the data, Guangming Agriculture and Animal Husbandry is a subsidiary of Shanghai Meilin Holdings, and Shanghai Meilin holds 41% of the shares. Jiangsu Zhongwang is a subsidiary of Guangming Agriculture and Animal Husbandry and Shanghai Meilin Holdings Sun Company. Before this transaction, Guangming Agriculture and Animal Husbandry held 64% of the shares of Jiangsu Zhongwang. On July 26th, the meeting of the board of directors of Shanghai Meilin passed the Proposal on Restructuring Equity and Debt of Subsidiaries, and agreed that Guangming Agriculture and Animal Husbandry would acquire 30% equity of Jiangsu Zhongwang held by Yuhang Wentou by public delisting. It is agreed that Sun Company Jiangsu Zhongwang will transfer its 100% equity and related creditor’s rights in Huai ‘an Zhongwang by public listing.

  Shanghai Meilin said that this transaction will help the company to clarify the assets of the pig breeding sector and enhance the company’s core competitiveness and high-quality development level. This transaction will increase the company’s net profit of 6.93 million yuan in that year. The data has not been audited, and the final impact amount is subject to the company’s annual audit data.

  The controlling shareholder of Electric Wind Power intends to increase its shareholding by 1% to 2%.

  Electric Wind Power issued an announcement. Recently, the company received a written notice from its controlling shareholder, Shanghai Electric. Based on its confidence in the company’s future development and recognition of the company’s long-term investment value, and in order to further safeguard the interests of the company and all shareholders and stabilize market expectations, after deliberation and unanimous approval by its board of directors, it will voluntarily increase its holdings of the company’s shares. The planned cumulative number of shares will not be less than 1% of the company’s total shares, and the maximum will not exceed 2% of the company’s total shares. The price of holding more shares shall not exceed the audited net assets per share of the company at the end of the latest period (the audited net assets per share of the company by the end of 2022 is 5.36 yuan/share).

  Tianma Zhikong: Li Shoubin, Vice Chairman and Director, resigned.

  Tianma Zhikong announced this evening that the board of directors of the company recently received the resignation report of Li Shoubin, vice chairman and director of the company.

  According to the announcement, Li Shoubin applied to resign as the vice chairman and director of the company due to job changes. Li Shoubin’s resignation will not cause the number of members of the company’s board of directors to be lower than the legal minimum, and will not affect the normal operation of the company’s board of directors. His resignation will take effect when the resignation report is delivered to the company’s board of directors.

  As of the date of announcement, Li Shoubin indirectly holds 5.31 million shares of the company through Tianjin Yuanzhi Tianma Management Consulting Partnership (Limited Partnership) and Tianjin Zhicheng Tianma Management Consulting Partnership (Limited Partnership), accounting for 1.2263% of the company’s total share capital. After this resignation, Li Shoubin will continue to strictly abide by the Company Law, science and technology innovation board Stock Listing Rules of Shanghai Stock Exchange, Several Provisions on Shareholding Reduction by Shareholders and Directors, Supervisors and Senior Managers of Listed Companies of Shanghai Stock Exchange, and other relevant laws, regulations and normative documents, and strictly fulfill his public commitments.

  Yirui Technology: The actual controller was changed to TIEER GU.

  Yirui Science and Technology announced that TIEER GU, CHENGBIN QIU, Cao Hongguang and Yang Weizhen signed the Agreement on Concerted Action in December 2017, and after friendly negotiation by all parties, they signed and issued the Notice on Non-renewal of the Agreement on Concerted Action on September 17, 2023, confirming that the above-mentioned Agreement on Concerted Action will not be renewed after the expiration of the validity period, and the rights relationship between all parties based on the Agreement on Concerted Action will be terminated on September 17, 2023. Before the expiration of the agreement on concerted action, the company had no controlling shareholder, and the actual co-controllers of the company were TIEER GU, CHENGBIN QIU, Cao Hongguang and Yang Weizhen. After the expiration and termination of this concerted action agreement, the actual controllers of the company were changed from TIEER GU, CHENGBIN QIU, Cao Hongguang and Yang Weizhen to TIEER GU. CHENGBIN QIU still serves as the company’s director and deputy general manager, and Cao Hongguang and Yang Weizhen still serve as the company’s directors. CHENGBIN QIU, Cao Hongguang and Yang Weizhen still need to abide by the provisions of relevant laws, regulations and normative documents such as the Measures for the Administration of Takeovers of Listed Companies, Several Provisions on Shareholder and Dong Jiangao’s Reduction of Shares.

  The controlling shareholder of Yuanlong Yatu terminated the reduction plan ahead of schedule, and the vice president of Xi ‘an Bank increased his holdings by nearly 220,000 shares.

  According to national business daily’s incomplete statistics, as of 20:00 on September 18th, 2023, there were 8 companies in Shanghai and Shenzhen stock markets that issued relevant announcements about shareholders or actual controllers changes in equity. Among them, () (002878.SZ, share price of 17.4 yuan, market value of 3.883 billion yuan) some shareholders ended the reduction plan ahead of schedule; In order to stabilize the stock price, Electric Wind Power (688660.SH, stock price of 5.10 yuan, market value of 6.8 billion yuan) disclosed the plan to increase shareholders’ holdings; Xi ‘an Bank (600928.SH, share price 3.58 yuan, market value 15.911 billion yuan) announced the results of shareholders’ increase.

  Yuanlong Yatu announced that the company had received a letter of notification from the controlling shareholder Yuanlong Yatu (Beijing) Investment Co., Ltd. (hereinafter referred to as "Yuanlong Investment") and its concerted action person Li Suqin, the company’s directors Xiang Jing, Yue Xin and Bian Yuchen, the supervisor Li Ya, and senior managers Chen Tao, Zhao Huaidong and Rao Xiuli. Based on their confidence in the future development of the company, the above shareholders decided to terminate the share reduction plan ahead of schedule.

  According to the announcement of Electric Wind Power, according to the Plan for Stabilizing the Company’s Stock Price within Three Years after the Listing of Shanghai Electric Wind Power Group Co., Ltd. (hereinafter referred to as the "Stock Price Stabilization Plan"), the company will take measures to stabilize the company’s stock price by directors and senior managers who meet the conditions stipulated in the Stock Price Stabilization Plan.

  Specifically, there are 8 people who meet the above plan, and the cumulative amount of shares increased by 8 Dong Jiangao is not less than 5% of their total after-tax remuneration in the previous year, but not more than 10% of their total after-tax remuneration in the previous year, that is, the total amount is not less than RMB 345,500, and the maximum amount is not more than RMB 691,100.

  It is reported that before starting the increase of senior executives’ holdings, the stock price stabilization plan also stipulated the starting sequence and conditions in the preface: First, the price of the company’s shares repurchased by the company should not exceed the company’s latest audited net assets per share, the single amount should not exceed 20% of the net profit returned to the mother in the previous year, and the total repurchase funds in a single fiscal year should not exceed 40% of the net profit returned to the mother. If the above standards are exceeded, the measures to stabilize the stock price will not be implemented in the current year.

  Second, the amount of the controlling shareholder’s shareholding in the company shall not exceed the dividend received from the company in the previous year, the price of the shareholding shall not exceed the latest audited net assets per share of the company, and the single and/or continuous 12-month shareholding shall not exceed 2% of the total shares of the company.

  In addition, Xi ‘an Bank announced that based on the confidence in the company’s future development prospects and the recognition of its growth value, Di Hao, the company’s vice president, increased his holding of 216,500 shares of the company with his own funds, with the price range of 3.57 yuan/share to 3.65 yuan/share.

  The actual controller of Yirui Technology was changed to TIEER GU.

  Yirui Science and Technology announced that the company recently received the Notice Letter on No Renewal of Concerted Action Agreement upon Expiration from TIEER GU, CHENGBIN QIU, Cao Hongguang and Yang Weizhen, confirming that the Concerted Action Agreement signed by all parties in December 2017 and the Supplementary Agreement signed in May 2019 expired on September 17, 2023, and all parties unanimously decided not to renew the new Concerted Action Agreement. After the expiration and termination of the Concerted Action Agreement, the actual controllers of the company were changed from TIEER GU, CHENGBIN QIU, Cao Hongguang and Yang Weizhen to TIEER GU.

  The merger of Chongqing Department Store and Chongqing Trading Group was suspended by the Restructuring Committee of Shanghai Stock Exchange.

  () Announcement: On September 18, 2023, the company received the Announcement on the Results of the 6th Review Meeting of the Review Committee on Mergers and Acquisitions of Shanghai Stock Exchange in 2023 issued by the Review Committee on Mergers and Acquisitions of Shanghai Stock Exchange. The Reorganization Committee of Shanghai Stock Exchange deliberated the company’s proposal to absorb and merge Chongqing Trading Company (Group) Co., Ltd. by issuing shares to Chongqing Yufu Capital Operation Group Co., Ltd., Tianjin Binhai New Area Wumei Jinrong Trading Co., Ltd., Shenzhen Jiajing Smart Retail Co., Ltd., Chongqing Trading Company Huilong Enterprise Management Consulting Partnership (Limited Partnership) and Chongqing Trading Company Huixing Enterprise Management Consulting Partnership (Limited Partnership), and the deliberation result was: the deliberation was suspended. Matters to be further implemented are as follows:

  1. The listed company is requested to make supplementary disclosure in the restructuring report: (1) the debt crisis of Shangshe Chemical in 2019 and the progress of bankruptcy liquidation procedures; (2) The specific situation of Pang Qingjun, the former chairman of Shangshe Chemical Industry, and the reasons and basis for identifying the debt crisis of state-owned enterprises caused by personal illegal and criminal acts; (3) Whether Chongqing Trading Co., Ltd. has participated in relevant illegal acts, failed to control its subsidiaries, and prepared financial reports containing significant error information, and failed to effectively prevent or timely discover the reasons for the chemical-related risks of the trading company; (4) If all the creditors of Chongqing Commercial Management and Trading Company Chemical sue Chongqing Trading Company, the maximum risk exposure of Chongqing Trading Company to compensate the debt; (5) If the listed company compensates the chemical debts of the trading company after this reorganization and recovers from the relevant parties, the accounting treatment of the listed company; (6) Whether this transaction is conducive to improving the asset quality of listed companies and enhancing their ability to continue operations. Please ask the independent financial adviser to check and express a clear opinion.

  2. The listed company is requested to: (1) Supplementary disclose the financial information of Chongqing Trading Company in the reorganization report in accordance with the provisions of the Standards for Contents and Forms of Information Disclosure of Companies Offering Securities to the Public No.26-Major Assets Reorganization of Listed Companies; (2) Supplementary disclosure of major financial data of trading company Huilong and trading company Huixing in the restructuring report.